C. Metzler

C M Metzler, J. Wagner, J G Wagner, 1968, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology.

Total Phenolics and Total Flavonoids in Selected Indian Medicinal Plants

Shinde, M. Mehdizadeh, C. Metzler, 2012 .

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

C. Metzler, R. Dehaan, R. DeHAAN, 1974, The Journal of infectious diseases.

Pharmacokinetic studies of clindamycin hydrochloride in humans.

C. Metzler, E. Masson, R. Dehaan, 1972, International journal of clinical pharmacology, therapy and toxicology.

Sample sizes for bioequivalence studies.

C. Metzler, 1991, Statistics in medicine.

Localization of leucocytes in sites of delayed-type hypersensitivity and in lymph nodes: dependence on vasoactive amines.

P. Askenase, R. Gershon, C. Metzler, 1982, Immunology.

Invertebrate Immunity. Mechanisms of Invertebrate Vector-Parasite Relations

C. Metzler, 1976, The Yale Journal of Biology and Medicine.

Estimation of the Life Span of Red Blood Cells in the Growing Animal in Different Nutritional States

C. Metzler, G. Matrone, M. W. Carter, 1965, The Journal of general physiology.

Pharmacokinetic studies of clindamycin phosphate.

C. Metzler, R. Dehaan, D. Schellenberg, 1973, Journal of clinical pharmacology.

Mathematical properties of compartment models with Michaelis-Menton type elimination

C. Metzler, C. M. Metzler, D.D.M. Tong, 1980 .

Clindamycin bioavailability from clindamycin-2-palmitate and clindamycin-2-hexadecylcarbonate in man

C. Metzler, Arlington A. Forist, Ray M. DeHaan, 1973, Journal of Pharmacokinetics and Biopharmaceutics.

Two stages of B-cell memory development with different T-cell requirements

C. Metzler, K. Okumura, T. Tsu, 1976, The Journal of experimental medicine.

Clindamycin dose-bioavailability relationships.

C. Metzler, R. Dehaan, D. Schellenberg, 1973, Journal of pharmaceutical sciences.

Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression.

E. Engleman, C. Benike, C. Metzler, 1983, Journal of immunology.

Prediction of blood levels after multiple doses from single-dose blood level data: data generated with two-compartment open model analyzed according to the one-compartment open model.

C M Metzler, J. Wagner, J G Wagner, 1969, Journal of pharmaceutical sciences.

Ciprostene in patients with peripheral vascular disease (PVD). An open-label, tolerance trial.

C. Metzler, O. Linet, J. Luderer, 1988, Prostaglandins, leukotrienes, and essential fatty acids.

Extended least squares (ELS) for pharmacokinetic models.

C M Metzler, C. Metzler, 1987, Journal of pharmaceutical sciences.

Clinical Predictors of Catheter Use Following Implantation of Intravenous Access Devices in Cystic Fibrosis Patients

D. Homnick, C. Metzler, R. Formoli, 1993, Clinical pediatrics.

Linear and nonlinear system approaches in pharmacokinetics: How much do they have to offer? II. The response mapping operator (RMO) approach

Harold Boxenbaum, Peter Veng-Pedersen, Ronald A. Siegel, 1988, Journal of Pharmacokinetics and Biopharmaceutics.

Medical and Statistical Design Issues in Clinical Pharmacology

C. Metzler, J. Vanderlugt, 1990 .

Estimation of rate constants for absorption and elimination from blood concentration data.

C M Metzler, J. Wagner, J G Wagner, 1967, Journal of pharmaceutical sciences.

Curve fitting and modeling in pharmacokinetics: A response

G. Elfring, C. Metzler, 1978, Journal of Pharmacokinetics and Biopharmaceutics.

Computational problems of compartment models with Michaelis-Menten-type elimination.

C. Metzler, D. Tong, 1981, Journal of pharmaceutical sciences.

Statistical Methods for Bioavailability and Bioequivalence

C. Metzler, D. C. Huang, 1983 .

On some stochastic formulations and related statistical moments of pharmacokinetic models

J. H. Matis, T. E. Wehrly, T. Wehrly, 1983, Journal of Pharmacokinetics and Biopharmaceutics.

MECHANISM OF ALLOTYPE SUPPRESSION IN MICE

C. Metzler, L. Herzenberg, 1974 .

ANTIBODY INDUCED SUPPRESSOR T-CELLS

Leonore A. Herzenberg, L. Herzenberg, C. Metzler, 1974 .

Biopharmaceutical statistics for drug development

Carl M. Metzler, C. Metzler, 1988 .

The Phenytoin Trial is a Case Study of ‘Individual’ Bioequivalence

R. Shumaker, C. Metzler, 1998 .

Extended Hildebrand solubility approach: testosterone and testosterone propionate in binary solvents.

M. Mehdizadeh, C. Metzler, A. Adjei, 1982, Journal of pharmaceutical sciences.

Pharmacokinetics and pharmacodynamics of oral diazepam: Effect of dose, plasma concentration, and time

C M Metzler, E J Antal, J S Harmatz, 1992, Clinical pharmacology and therapeutics.

Effects of a fish oil concentrate in patients with hypercholesterolemia.

C. Metzler, O. Linet, G. Peters, 1988, Atherosclerosis.

Nasal airway response to infused phenylephrine in normals and in patients with allergic and non-allergic rhinitis.

C. Metzler, C. D. Brooks, K. J. Karl, 1988, Rhinology.

Clinical experience with cefmetazole sodium in the United States: an overview.

C. Metzler, E. Novak, L. Paxton, 1989, The Journal of antimicrobial chemotherapy.

Treatment of ragweed hay fever with flurbiprofen, a cyclooxygenase-inhibiting drug.

C. Metzler, C. D. Brooks, A. Nelson, 1985, Annals of allergy.

Pharmaceutical statistics: Practical and clinical applications. Second edition. By Sanford Bolton. Marcel Dekker: New York. 1990. xvii + 646 pp. 16 × 23 cm. ISBN 0‐8247‐8267‐4, $ 99.75

C. Metzler, 1991 .

Multiclinic Double‐Blind Comparison of Triazolam and Flurazepam for Seven Nights in Outpatients with Insomnia

C. Metzler, Ludwig Gross, LOUIS P. Fabre, 1977, Journal of clinical pharmacology.

Efficacy and Residual Effect Evaluation of a New Hypnotic, Triazolam

C. Metzler, R. N. Straw, W. Veldkamp, 1974, Journal of clinical pharmacology.

The effect of substrate availability on the metabolism of arachidonic acid in human platelets.

F. Sun, C. Metzler, J. C. Mcguire, 1981, Progress in lipid research.

Experiments with mixtures: Designs, models, and the analysis of mixture data. Second edition. By John A. Cornell. John Wiley: New York. 1990. xix + 631 pp. 16 × 23 cm. ISBN 0‐471‐52221‐X. $59.95

Carl M. Metzler, C. Metzler, 1991 .

A mathematical model for the pharmacokinetics of LSD effect

G. Levy, C. Metzler, D. Mainland, 1969, Clinical pharmacology and therapeutics.

The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteers

J. Ferry, C. Metzler, J. Luderer, 2004, European Journal of Clinical Pharmacology.

Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal.

L. Fabre, S. Kemple, C. Metzler, 1977, Journal of studies on alcohol.